Infectious Disease Diagnostics – News and Features

By measuring randomness in DNA methylation, researchers identified early-stage cancers with high accuracy. The method outperformed traditional methylation tests.

Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal resistance in under 40 minutes. The assay provides rapid, precise results from swab samples.

In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and redefining the standard of care for infectious diseases.

Vaccine-induced false positives are a major roadblock in the development of an HIV vaccine, according to a research team at Penn State. The researchers developed a test that can differentiate between false positives and active HIV infections.

E. coli can prevent infected gut cells from being pushed out by targeting enzymes critical to the body’s first defense, according to new research in Nature.

AI-supported cervical cancer screening in Kenya shows promise for improving healthcare access in resource-limited settings.

Two recent papers have laid out a road map for such a tool, detailing the development and validation of a collection of blood tests that would provide answers to all of these questions.

Researchers have found a way to amplify detection of tuberculosis in low-concentration samples, resulting in a tongue swab test that delivers results in 45 minutes.

Using machine learning algorithms and human gut bacteria, scientists have developed a new low-cost screening method for detecting colorectal cancer.

Scientists have developed a new diagnostic test that uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.